Detection, pathogenesis, and therapy of respiratory syncytial virus infections.

AUTOR(ES)

Welliver, R C

RESUMO

Respiratory syncytial virus (RSV) infection is a major cause of serious lower respiratory disease in infancy and early childhood. The unique pathogenesis of lower respiratory illness due to RSV offers some intriguing clues to the role of the human immune system in both protection against and development of respiratory illness. More than any other virus, rapid diagnostic techniques have been especially successful in identifying RSV infection. Many of these techniques could be easily adaptable to diagnosis of influenza virus infection and other agents. Finally, ribavirin therapy of RSV infection represents one of the few instances in which antiviral therapy has been shown to be effective for respiratory illnesses. Fundamental observations in these areas in the case of RSV infection open up new and exciting pathways for investigation of respiratory infection due to other viral, chlamydial, and mycoplasmal agents.

Documentos Relacionados

• Practical recommendations for the detection of pediatric respiratory syncytial virus infections.
• Safety and pharmacokinetics of vitamin A therapy for infants with respiratory syncytial virus infections.
• Exposure of health care workers to ribavirin during therapy for respiratory syncytial virus infections.
• Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections.
• Simultaneous Detection, Subgrouping, and Quantitation of Respiratory Syncytial Virus A and B by Real-Time PCR